Conmed will begin trading on the NYSE Feb. 10. It will retain the same ticker symbol, CNMD. CEO Curt Hartman said the move will align Conmed with the “high-performing medical device companies traded on the NYSE.”
NYSE Chief Commercial Officer John Tuttle spoke highly of Conmed, saying, “We look forward to collaborating with the company and continuously delivering the benefits of our unique market model and world-class services.”
More articles on surgery centers:
How will the ASC industry change? 6 experts weigh in
Pacific Rim Outpatient Surgery Center acquired by PeaceHealth: 4 details
Physician Partners of America opens Florida surgery center
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.